Comments
Loading...

Arcus Biosciences

RCUSNYSE
Logo brought to you by Benzinga Data
$15.09
-0.41-2.65%
Pre-Market: Dec 20, 5:40 PM EDT

Arcus Biosciences (NYSE:RCUS) Stock Quotes, Forecast and News Summary

Arcus Biosciences Stock (NYSE: RCUS) stock price, news, charts, stock research, profile.

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trends and Forecast
1
Jun
2
Jul
2
1
Aug
5
2
Oct
1
Nov
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
Open-
Close-
Volume / Avg.2.00 / 772.29K
Day Range- - -
52 Wk Range13.52 - 20.31
Market Cap$1.38B
P/E Ratio-
Dividend Yield-
ExchangeNYSE
RSI
41
Short Interest
18.13%
Days to Cover12.88

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
RCUS
SPRY

FAQ

Q

How do I buy Arcus Biosciences (RCUS) stock?

A

You can purchase shares of Arcus Biosciences (NYSE:RCUS) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Arcus Biosciences (RCUS) competitors?

Q

What is the forecast, or price target, for Arcus Biosciences (RCUS) stock?

A

Arcus Biosciences has a consensus price target of $37.00.

Q

What is the current price for Arcus Biosciences (RCUS)?

A

The stock price for Arcus Biosciences (NYSE: RCUS) is $15.09 last updated December 20, 2024 at 5:40 PM EST.

Q

Does Arcus Biosciences (RCUS) pay a dividend?

A

There are no upcoming dividends for Arcus Biosciences.

Q

When is Arcus Biosciences (NYSE:RCUS) reporting earnings?

A

Arcus Biosciences’s Q4 earnings are confirmed for Wednesday, February 19, 2025.

Q

Is Arcus Biosciences (RCUS) going to split?

A

There is no upcoming split for Arcus Biosciences.

Q

What sector and industry does Arcus Biosciences (RCUS) operate in?

A

Arcus Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NYSE.

People Also Watch